A Blood Test to Look at Cells of the Immune System in Healthy Children
NCT00001109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 630
Last updated 2008-07-30
Summary
The purpose of this study is to learn more about some of the immune cells in the blood (CD4 cells, for example) of healthy children in order to better understand the differences in the blood cells of children infected with HIV.
Because children's bodies are still developing, their cells are different from those of adults, and their bodies respond differently to infections such as HIV. In order to understand how immune cells grow and mature so that they can fight HIV, it is important to see how these cells behave in normal children.
Conditions
- HIV Infections
- HIV Seronegativity
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
W Shearer
-
H Rosenblatt
Eligibility
- Min Age
- 1 Day
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Immune Function of Infants With HIV
NCT00073229 ·Status: COMPLETED
-
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
NCT00016783 ·Status: COMPLETED
-
Vitamin D Supplementation and CD4 Count in HIV-Infected Children
NCT00911664 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History Study of HIV Acquired in Infancy or Childhood
NCT00924365 ·Status: COMPLETED
-
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
NCT00006325 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children
NCT03984552 ·Status: UNKNOWN
-
A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
NCT00000716 ·Status: COMPLETED ·Phase: PHASE2
-
Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
NCT00001826 ·Status: COMPLETED
-
A Study of 1592U89 in HIV-Infected Children
NCT00002197 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
NCT00000952 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children
NCT00260806 ·Status: COMPLETED
-
Developing Newborn Screening for Infants With Primary Immunodeficiency
NCT00113464 ·Status: COMPLETED
-
Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants
NCT00342082 ·Status: COMPLETED
-
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
NCT00013871 ·Status: COMPLETED ·Phase: NA
-
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
NCT00992017 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
NCT02256631 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 ·Status: COMPLETED
-
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
NCT00039741 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV
NCT05923333 ·Status: RECRUITING ·Phase: NA
-
UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children
NCT05993767 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent
NCT01771562 ·Status: COMPLETED
-
A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
NCT00000669 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications
NCT00001078 ·Status: COMPLETED ·Phase: NA
-
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
NCT00120471 ·Status: COMPLETED ·Phase: PHASE1